FDA OKs 2-Drug Combo Treatment for Advanced Melanoma
In trial, Mekinist and Tafinlar together seemed to perform better than Tafinlar alone, agency saysContinue Reading
In trial, Mekinist and Tafinlar together seemed to perform better than Tafinlar alone, agency saysContinue Reading
The most deadly form of skin cancerContinue Reading
Study found adding new drug obinutuzumab extended remission in chronic lymphocytic leukemiaContinue Reading
Cigarette tax hikes, no-smoking policies contribute to decline, experts say
Continue Reading
But many are still lighting up a year later, study findsContinue Reading
Extended treatment combined with talk therapy might be most effective, researcher saysContinue Reading
But almost one-fifth of Americans still light upContinue Reading
But many are still lighting up a year later, study findsContinue Reading
Extended treatment combined with talk therapy might be most effective, researcher saysContinue Reading
But almost one-fifth of Americans still light upContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.